Evidence map›Paper›PMID 40423053›Full record

ArticleJournal of personalized medicine2025

Central Nervous System Metastases from Primary Lung Carcinoma: Significance of RNA Fusion Testing and Early Versus Late Metastases.

Michelle Garlin Politis, Mahesh Mansukhani, Benjamin O Herzberg, Lanyi N Chen, Mark Stoopler, Maelle Saliba, Markus Siegelin, Zhe Zhu, Joshua Sonett, Brian S Henick and 8 more

Abstract read
In one paragraph

Article in Journal of personalized medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Michelle Garlin PolitisDepartment of Pathology and Cell Biology, Columbia University Irving Medical Center, New York Presbyterian Hospital, New York, NY 10032, USA.ORCID 0000-0003-2501-601X
Mahesh MansukhaniDepartment of Pathology and Cell Biology, Columbia University Irving Medical Center, New York Presbyterian Hospital, New York, NY 10032, USA.ORCID 0000-0003-2044-0751
Benjamin O HerzbergDivision of Hematology and Oncology, Columbia University Irving Medical Center, New York Presbyterian Hospital, New York, NY 10032, USA.
Lanyi N ChenDivision of Hematology and Oncology, Columbia University Irving Medical Center, New York Presbyterian Hospital, New York, NY 10032, USA.
Mark StooplerDivision of Hematology and Oncology, Columbia University Irving Medical Center, New York Presbyterian Hospital, New York, NY 10032, USA.
Maelle SalibaDepartment of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Markus SiegelinDepartment of Pathology and Cell Biology, Columbia University Irving Medical Center, New York Presbyterian Hospital, New York, NY 10032, USA.
Zhe ZhuDepartment of Pathology and Cell Biology, Columbia University Irving Medical Center, New York Presbyterian Hospital, New York, NY 10032, USA.ORCID 0000-0002-5385-948X
Joshua SonettDivision of Thoracic Surgery, Columbia University Irving Medical Center, New York Presbyterian Hospital, New York, NY 10032, USA.
Brian S HenickDivision of Hematology and Oncology, Columbia University Irving Medical Center, New York Presbyterian Hospital, New York, NY 10032, USA.
Simon K ChengDivision of Radiation Oncology, Columbia University Irving Medical Center, New York Presbyterian Hospital, New York, NY 10032, USA.
Swarnali AcharyyaDepartment of Pathology and Cell Biology, Columbia University Irving Medical Center, New York Presbyterian Hospital, New York, NY 10032, USA.
Catherine A ShuDivision of Hematology and Oncology, Columbia University Irving Medical Center, New York Presbyterian Hospital, New York, NY 10032, USA.ORCID 0000-0003-0765-7665
Michael L MillerDepartment of Pathology and Cell Biology, Columbia University Irving Medical Center, New York Presbyterian Hospital, New York, NY 10032, USA.ORCID 0000-0002-6350-5706
Benjamin IzarDivision of Hematology and Oncology, Columbia University Irving Medical Center, New York Presbyterian Hospital, New York, NY 10032, USA.ORCID 0000-0003-2379-6702
Helen FernandesDepartment of Pathology and Cell Biology, Columbia University Irving Medical Center, New York Presbyterian Hospital, New York, NY 10032, USA.ORCID 0000-0003-4548-1904
Susan HsiaoDepartment of Pathology and Cell Biology, Columbia University Irving Medical Center, New York Presbyterian Hospital, New York, NY 10032, USA.ORCID 0000-0002-0319-4969
Anjali SaqiDepartment of Pathology and Cell Biology, Columbia University Irving Medical Center, New York Presbyterian Hospital, New York, NY 10032, USA.ORCID 0000-0003-3133-9886

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CNS metastaseslung carcinomaNGSRNA fusion testing

Identifiers

PMID40423053
PMCPMC12112828

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.